Skip to main content

Clinical trial INCB59872-101

A Phase 1/2, Open-Label, Dose-Escalation / Dose-Expansion, Safety and Tolerability Study of INCB059872 in Subjects With Advanced Malignancies

Organ Tumeurs solides
Trial status Trial closed for recruitment
Trial type
Interventionnal with IMP
Phase Trial phase 1/2
Academic trial Non
Sponsor Incyte Corporate
EudraCT Identifier 2017-001710-28
Inclusion criteria Any line
Last update